RecallDepth
Class III Terminated

Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NC 27709, NDC 49702-228-13.

Company
Glaxosmithkline, Llc.
Recall Initiated
May 13, 2022
Posted
June 1, 2022
Recall Number
D-0896-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
328 bottles
Firm Location
Zebulon, NC, United States

Reason for Recall

Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration date is September 2026.

Distribution

Nationwide in the U.S.

Lot / Code Info

Lot: 2A9E, Exp 1/2027

More recalls by Glaxosmithkline, Llc.

View all recalls by this company →

Other recent Class III Drug recalls